Collegium Pharmaceutical (COLL) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to -$285.9 million.
- Collegium Pharmaceutical's Enterprise Value fell 13830.46% to -$285.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$285.9 million, marking a year-over-year decrease of 13830.46%. This contributed to the annual value of -$162.8 million for FY2024, which is 4758.85% up from last year.
- Per Collegium Pharmaceutical's latest filing, its Enterprise Value stood at -$285.9 million for Q3 2025, which was down 13830.46% from -$222.2 million recorded in Q2 2025.
- In the past 5 years, Collegium Pharmaceutical's Enterprise Value ranged from a high of -$106.7 million in Q1 2022 and a low of -$325.5 million during Q2 2023
- In the last 5 years, Collegium Pharmaceutical's Enterprise Value had a median value of -$197.8 million in 2025 and averaged -$215.3 million.
- As far as peak fluctuations go, Collegium Pharmaceutical's Enterprise Value tumbled by 16520.92% in 2023, and later skyrocketed by 6061.37% in 2024.
- Collegium Pharmaceutical's Enterprise Value (Quarter) stood at -$186.4 million in 2021, then increased by 6.83% to -$173.7 million in 2022, then tumbled by 78.8% to -$310.5 million in 2023, then surged by 47.59% to -$162.8 million in 2024, then crashed by 75.63% to -$285.9 million in 2025.
- Its Enterprise Value stands at -$285.9 million for Q3 2025, versus -$222.2 million for Q2 2025 and -$197.8 million for Q1 2025.